BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24495680)

  • 41. Differential indication for histological evaluation of endometrial fluid in postmenopause.
    Schmidt T; Nawroth F; Breidenbach M; Hoopmann M; Mallmann P; Valter MM
    Maturitas; 2005 Mar; 50(3):177-81. PubMed ID: 15734598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
    Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
    Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective comparison of biopsy results from curettage and hysteroscopy in postmenopausal uterine bleeding.
    Lee DO; Jung MH; Kim HY
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1423-6. PubMed ID: 21651668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microscale endometrial sampling biopsy in detecting endometrial cancer and atypical hyperplasia in a population of 1551 women: a comparative study with hysteroscopic endometrial biopsy.
    Zhang G; Wang Y; Liang XD; Zhou R; Sun XL; Wang JL; Wei LH
    Chin Med J (Engl); 2020 Sep; 134(2):193-199. PubMed ID: 33009021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experience with Endopap endometrial sampling in the cytodiagnosis of endometrial carcinoma and its precursor lesions. I. A correlative cytologic-histologic-hysteroscopic diagnostic pilot study.
    Suprun HZ; Taendler-Stolero R; Schwartz J; Ettinger M
    Acta Cytol; 1994; 38(3):319-23. PubMed ID: 8191819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
    Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
    J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of endometrial hyperplasia in women with abnormal uterine bleeding.
    Loverro G; Bettocchi S; Vicino M; Selvaggi L
    Acta Eur Fertil; 1994; 25(1):23-5. PubMed ID: 7887077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Atypical hyperplasia of endometrium and hysteroscopy].
    Agostini A; Schaeffer V; Cravello L; Bretelle F; Roger V; Blanc B
    Gynecol Obstet Fertil; 2003 Apr; 31(4):355-8. PubMed ID: 12821066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.
    Garuti G; Sagrada PF; Frigoli A; Fornaciari O; Finco A; Mirra M; Soligo M
    Arch Gynecol Obstet; 2023 Sep; 308(3):971-979. PubMed ID: 37160470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Narrow-band imaging in diagnosis of endometrial cancer and hyperplasia: a new option?
    Surico D; Vigone A; Bonvini D; Tinelli R; Leo L; Surico N
    J Minim Invasive Gynecol; 2010; 17(5):620-5. PubMed ID: 20579943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hysteroscopy and directed biopsy in the diagnosis of endometrial carcinoma.
    Zhu HL; Liang XD; Wang JL; Cui H; Wei LH
    Chin Med J (Engl); 2010 Dec; 123(24):3524-8. PubMed ID: 22166624
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The role of hysteroscopy in the diagnosis and follow-up of endometrial hyperplasia].
    Gubbini G; Filoni M; Linsalata I; Stagnozzi R; Stefanetti M; Marabini A
    Minerva Ginecol; 1998 Apr; 50(4):125-33. PubMed ID: 9691636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Precancerous lesions of the endometrium and medical treatment.
    Taddei GL; Bargelli G; Scarselli B; Moncini D; Scarselli G
    Eur J Contracept Reprod Health Care; 1997 Dec; 2(4):239-41. PubMed ID: 9678079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
    Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
    Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
    Haoula ZJ; Walker KF; Powell MC
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pay attention to screening of endometrial carcinoma].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):881-3. PubMed ID: 24495677
    [No Abstract]   [Full Text] [Related]  

  • 60. Pre-sampling ultrasound evaluation and assessment of the tissue yield during sampling improves the diagnostic reliability of office endometrial biopsy.
    Van den Bosch T; Van Schoubroeck D; Van Calster B; Cornelis A; Timmerman D
    J Obstet Gynaecol; 2012 Feb; 32(2):173-6. PubMed ID: 22296431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.